Assessing regression to the mean effects in health care initiatives

BMC Medical Research Methodology

Volumn 13, Issue 1, 2013, Pages

  Linden, Ariel ^a,b  

^a LINDEN CONSULTING GROUP   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Confidence intervals; Outcomes; Outliers; Regression to the mean; Simulation; Validity

Indexed keywords

ALGORITHM; CASE CONTROL STUDY; COMPUTER SIMULATION; EVALUATION STUDY; HUMAN; MONTE CARLO METHOD; STATISTICAL ANALYSIS; STATISTICAL MODEL; TREATMENT OUTCOME; ARTICLE;

ALGORITHMS; CASE-CONTROL STUDIES; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; EVALUATION STUDIES AS TOPIC; HUMANS; MODELS, STATISTICAL; MONTE CARLO METHOD; TREATMENT OUTCOME;

EID: 84884656212     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-13-119     Document Type: Article

References (45)

1. Regression towards the mean. Bland JM, Altman DG, BMJ 1994 308 1499 10.1136/bmj.308.6942.1499 8019287 (Pubitemid 24170175)
2. The phenomenon of regression to the mean and clinical investigation of blood cholesterol lowering drugs. Boissel JP, Duperat B, Leizorowicz A, Eur J Clin Pharmacol 1980 17 227 230 10.1007/BF00561905 6988223 (Pubitemid 10109222)
3. Regression to the mean in pretreatment measures of stuttering. Andrews G, Harvey R, J Speech Hear Disord 1981 46 204 207 7253599 (Pubitemid 11037399)
4. Blood pressure reductions: correcting for regression to the mean. Shepard DS, Finison LJ, Prev Med 1983 12 304 317 10.1016/0091-7435(83)90239-6 6878192 (Pubitemid 13065508)
5. Regression to the mean in treated versus untreated chronic pain. Whitney CW, Von Korff M, Pain 1992 5 281 285
6. Responses to a cholesterol-lowering diet: efficacy is greater in hypercholesterolemic subjects even after adjustment for regression to the mean. Denke MA, Frantz ID, Am J Med 1993 94 626 631 10.1016/0002-9343(93)90215-B 8506889 (Pubitemid 23166710)
7. Effect of regression to the mean in serial echocardiographic measurements of left ventricular mass: quantification and clinical implications. Herpin D, Demange J, Am J Hypertens 1994 7 824 828 7811441 (Pubitemid 24316033)
8. Evaluating cholesterol screening: the importance of controlling for regression to the mean. Forrow L, Calkins DR, Allshouse K, Horowitz G, Delbanco TL, Arch Intern Med 1995 155 2177 84 10.1001/archinte.1995.00430200056009 7487239
9. Regression to the mean occurs in measuring peak urinary flow. Prescott RJ, Garraway WM, Br J Urol 1995 76 611 613 10.1111/j.1464-410X.1995.tb07787.x 8535681 (Pubitemid 26029696)
10. Emergency department hypertension and regression to the mean. Pitts SR, Adams RP, Ann Emerg Med 1998 31 214 8 10.1016/S0196-0644(98)70309-9 9472183 (Pubitemid 28079694)
11. Ostensible day-night difference of QT prolongation during long-term treatment with antiarrhythmic drugs: reappraisal of the law of 'regression to the mean'. Murakawa Y, Yamashita T, Ajiki K, Sezaki K, Omata M, J Cardiovasc Pharmacol 1998 32 62 65 10.1097/00005344-199807000-00010 9676722 (Pubitemid 28304695)
12. Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Cummings SR, Palermo L, Browner W, Marcus R, Wallace R, Pearson J, Blackwell T, Eckert S, Black D, JAMA 2000 283 1318 1321 10.1001/jama.283.10.1318 10714731 (Pubitemid 30129799)
13. Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension. Asmar R, Safar M, Oueneau P, Am J Hypertens 2001 14 6 Pt 1 546 552 11411734 (Pubitemid 32506728)
14. Changes in biochemical markers of bone turnover in women treated with Raloxifene: influence of regression to the mean. Chapurlat RD, Blackwell T, Bauer DC, Cummings SR, Osteoporosis Int 2001 12 1006 1014 10.1007/s001980170009 (Pubitemid 34105970)
15. Magnitude of the regression to the mean within one-year intra-individual changes in serum lipid levels among Japanese male workers. Takashima Y, Sumiya Y, Kokaze A, Yoshida M, Ishikawa M, Sekine Y, Akamatsu S, J Epidemiol 2001 11 61 69 10.2188/jea.11.61 11388494
16. Why do phase III trials of promising heart failure drugs often fail? The contribution of 'regression to the truth'. Krum H, Tonkin A, J Card Fail 2003 9 347 349 10.1054/j.cardfail.2003.08.006 14583893 (Pubitemid 37351800)
17. Understanding the relationship between baseline BMI and subsequent weight change in antipsychotic trials: Effect modification or regression to the mean? Allison DB, Loebel AD, Lombardo I, Romano SJ, Siu CO, Psychiatry Res 2009 170 172 176 10.1016/j.psychres.2008.10.007 19897253
18. Why Preoperative Acuity Predicts Postoperative Acuity in Wavefront-Guided LASIK. Aaron MT, Applegate RA, Porter J, Thibos LN, Schallhorn SC, Brunstetter TJ, Tanzer DJ, Optom Vis Sci 2010 87 861 866 10.1097/OPX.0b013e3181f6fb49 20871471
19. Mechanisms of change in control group drinking in clinical trials of brief alcohol intervention: Implications for bias toward the null. Bernstein JA, Bernstein E, Heeren TC, Drug Alcohol Rev 2010 29 498 507 10.1111/j.1465-3362. 2010.00174.x 20887573
20. Blood pressure status and post-exercise hypotension: an example of spurious correlation in hypertension research? Taylor CE, Jones H, Zaregarizi M, Cable NT, George KP, Atkinson G, J Hum Hypertens 2010 24 585 592 10.1038/jhh.2009.112 20054347
21. Dissection of the factors driving the placebo effect in hypnotic treatment of depressed insomniacs. McCall WV, D'Agostino R, Rosenquist PB, Kimball J, Boggs N, Lasater B, Blocker J, Sleep Med 2011 12 557 564 10.1016/j.sleep.2011.03.008 21601519
22. Effect of regression of the mean in decision making in health care. Morton V, Torgerson DJ, BMJ 2003 326 1083 1084 10.1136/bmj.326.7398.1083 12750214 (Pubitemid 36629731)
23. Judgment under uncertainty: Heuristics and biases. Tversky A, Kahneman D, Science 1974 185 1124 1131 10.1126/science.185.4157.1124 17835457
24. Use of the total population approach to measure U.S. disease management industry's cost savings: issues and implications. Linden A, Dis Manage Health Outc. 2007 15 13 18 10.2165/00115677-200715010-00003 (Pubitemid 46425640)
25. Regression towards mediocrity in hereditary stature. Galton F, J Anthropol Inst 1886 15 246 263
26. Campbell DT, Kenny DA, A Primer on Regression Artifacts New York: Guilford Press 1999
27. Some effects of within person variability in epidemiological studies. Gardner MJ, Heady JA, J Chronic Dis 1973 26 781 795 10.1016/0021-9681(73)90013-1
28. Effect of regression to the mean in the presence of within-subject variability. Johnson WD, George VT, Stat Med 1991 10 1295 1302 10.1002/sim.4780100812 1925160
29. An assessment of the total population approach for evaluating disease management program effectiveness. Linden A, Adams J, Roberts N, Dis Manage 2003 6 93 102 10.1089/109350703321908478 (Pubitemid 36835151)
30. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Ware JE Jr, Kosinski M, Keller SD, Med Care 1996 34 220 233 10.1097/00005650-199603000-00003 8628042 (Pubitemid 126433231)
31. The effect of motivational interviewing-based health coaching on employees' physical and mental health status. Butterworth S, Linden A, McClay M, Leo MC, J Occup Healt Psych 2006 11 358 365 (Pubitemid 44629930)
32. Ware JE, Losinski M, Turner-Bowker DM, Gandek B, How to Score Version 2 of the SF-12® Health Survey (With a Suppl. Documenting Version 1) Lincoln, RI: QualityMetric Incorporated 2002 24041354
33. The effect of regression to the mean in epidemiologic and clinical studies. Davis CE, Am J Epidemiol 1976 104 493 498 984023
34. Regression to the mean: what it is and how to deal with it. Barnett AG, van der Pols JC, Dobson AJ, Int J Epidemiol 2005 34 215 220 15333621 (Pubitemid 40347398)
35. Non-normal variation and regression to the mean. Chesher A, Stat Methods Med Res 1997 6 147 166 10.1191/096228097672663908 9261913 (Pubitemid 127570361)
36. Assessing the regression to the mean for non-normal populations via kernel estimators. Majnu J, Abbas FJ, N Am J Med Sci 2010 2 288 292 22558576
37. Regression discontinuity designs in econometrics. Lee DS, Lemieux T, J Econ Lit 2010 48 281 355 10.1257/jel.48.2.281
38. Combining the regression-discontinuity design and propensity-score based weighting to improve causal inference in program evaluation. Linden A, Adams JL, J Eval Clin Pract 2012 18 317 325 10.1111/j.1365-2753.2011.01768.x 22304484
39. How to deal with regression to the mean in intervention studies. Yudkin PL, Stratton IM, Lancet 1996 347 241 243 10.1016/S0140-6736(96)90410-9 8551887 (Pubitemid 26035252)
40. Estimating the effect of regression to the mean in health management programs. Linden A, Dis Manage and Healt Outc 2007 15 7 12 10.2165/00115677- 200715010-00002 (Pubitemid 46425639)
41. Matching methods for causal inference: a review and a look forward. Stuart EA, Stat Sci 2010 25 1 21 10.1214/09-STS313 20871802
42. Regression toward the mean and the regression-effect bias. Roberts AOH, New Directions for Testing and Measurement San Francisco: Jossey-Bass, Echternacht G, 1980 59 82
43. Estimating an individual's true cholesterol level and response to intervention. Irwig L, Glasziou P, Wilson A, Macaskill P, JAMA 1991 266 1678 85 10.1001/jama.1991.03470120080037 1886192
44. Trochim WMK, The Research Methods Knowledge Base Cincinnati: Ohio, Atomic Dog Publishing 2 2001
45. Shadish SR, Cook TD, Campbell DT, Experimental and quasi-experimental designs for generalized causal inference Boston: Houghton Mifflin 2002